GF Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

GF Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.23M	Buy	56,106 +593	+1%	+$34.1K	0.04%	146
2026 Q1	$3.37M	Hold	55,513	–	–	0.06%	144
2025 Q4	$2.99M	Sell	55,513 -1,047	-2%	-$50.4K	0.05%	157
2025 Q3	$2.55M	Buy	56,560 +7,181	+15%	+$335K	0.05%	166
2025 Q2	$2.29M	Sell	49,379 -369	-0.7%	-$18.1K	0.05%	183
2025 Q1	$3.03M	Hold	49,748	–	–	0.07%	160
2024 Q4	$2.81M	Buy	+49,748	New	+$2.78M	0.06%	162

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GF Fund Management's BMY Position: Q2 2026 in Review

GF Fund Management increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $34.1K and bringing the position to 56,106 shares worth $3.23M. The position accounts for 0.04% of the portfolio, ranked #146.

GF Fund Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.37M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

GF Fund Management held 56,106 shares of Bristol-Myers Squibb worth $3.23M as of Q2 2026.
GF Fund Management bought 593 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.1K.
Bristol-Myers Squibb made up 0.04% of GF Fund Management's portfolio in Q2 2026, its #146 holding.
GF Fund Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Bristol-Myers Squibb position peaked at $3.37M in Q1 2026.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.